[1] |
INABA H, MULLIGHAN C G. Pediatric acute lymphoblastic leukemia[J]. Haematologica, 2020, 105(11):2524-2539.
DOI
PMID
|
[2] |
薛玉娟, 陆爱东, 王毓, 等. 微小残留病在儿童急性B淋巴细胞白血病预后中的意义[J]. 临床儿科杂志, 2021, 39(5):321-326.
|
[3] |
KRUSE A, ABDEL-AZIM N, KIM H N, et al. Minimal residual disease detection in acute lymphoblastic leukemia[J]. Int J Mol Sci, 2020, 21(3):1054.
DOI
URL
|
[4] |
黄走方, 许杰, 傅明伟, 等. 成人急性淋巴细胞白血病患者首疗程化疗结束时微小残留病检测对自体造血干细胞移植预后的意义[J]. 中华血液学杂志, 2019, 40(2):105-110.
|
[5] |
BARTRAM J, PATEL B, FIELDING A K. Monitoring MRD in ALL:methodologies,technical aspects and optimal time points for measurement[J]. Semin Hematol, 2020, 57(3):142-148.
DOI
URL
|
[6] |
危彤, 陈晓娟, 张陆阳, 等. 微小残留病在不同融合基因背景的急性B淋巴细胞白血病患儿中的临床意义[J]. 中国当代儿科杂志, 2020, 22(12):1279-1285.
|
[7] |
中华医学会儿科学分会血液学组,《中华儿科杂志》编辑委员会. 儿童急性淋巴细胞白血病诊疗建议(第四次修订)[J]. 中华儿科杂志, 2014, 52(9):641-644.
|
[8] |
高伟, 蒋梦影, 高莉, 等. 儿童急性淋巴细胞白血病治疗失败的相关因素分析[J]. 中国实验血液学杂志, 2021, 29(3):661-668.
|
[9] |
SUN C, CHANG L, ZHU X. Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse[J]. Oncotarget, 2017, 8(21):35445-35459.
DOI
URL
|
[10] |
徐一卓, 王西阁, 陈力溶. 河南地区248例儿童急性淋巴细胞白血病融合基因类型分析[J]. 郑州大学学报(医学版), 2019, 54(3):470-473.
|
[11] |
王邢玮, 李本尚, 沈树红, 等. ETV6/RUNX1阳性儿童急性B系淋巴细胞白血病临床预后研究[J]. 临床儿科杂志, 2016, 34(5):321-325.
|
[12] |
MONTAÑO A, ORDOÑEZ J L, ALONSO-PÉREZ V, et al. ETV6/RUNX1 fusion gene abrogation decreases the oncogenicity of tumour cells in a preclinical model of acute lymphoblastic leukaemia[J]. Cells, 2020, 9(1):215.
DOI
URL
|
[13] |
AMPATZIDOU M, PAPADHIMITRIOU S I, PATERAKIS G, et al. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia(ALL):the spectrum of clonal heterogeneity and its impact on prognosis[J]. Cancer Genet, 2018,224-225:1-11.
|
[14] |
BHOJWANI D, PEI D, SANDLUND J T, et al. ETV6-RUNX1-positive childhood acute lymphoblastic leukemia:improved outcome with contemporary therapy[J]. Leukemia, 2012, 26(2):265-270.
DOI
|
[15] |
WANG Y, ZENG H M, ZHANG L P. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China:excellent prognosis with improved BFM protocol[J]. Ital J Pediatr, 2018, 44(1):94.
DOI
|
[16] |
HOFFMANN J, KRUMBHOLZ M, GUTIÉRREZ H P, et al. High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia[J]. Pediatr Blood Cancer, 2019, 66(8):e27780.
|
[17] |
余洁明, 易甜甜, 林贯川, 等. 第19天微小残留病检测在儿童急性淋巴细胞白血病中的预后意义及危险因素分析[J]. 南方医科大学学报, 2020, 40(2):255-261.
|
[18] |
DELLA STARZA I, CHIARETTI S, DE PROPRIS M S, et al. Minimal residual disease in acute lymphoblastic leukemia:technical and clinical advances[J]. Front Oncol, 2019, 9:726.
DOI
URL
|
[19] |
中国免疫学会血液免疫分会临床流式细胞术学组. 多参数流式细胞术检测急性白血病及浆细胞肿瘤微小残留病中国专家共识(2017年版)[J]. 中华血液学杂志, 2017, 38(12):1001-1011.
|
[20] |
刘芳, 陈晓娟, 郭晔, 等. CCLG-ALL-2008方案治疗ETV6-RUNX1融合基因阳性儿童急性淋巴细胞白血病:单中心长期随访结果[J]. 中华血液学杂志, 2020, 41(11):896-902.
|
[21] |
郑湧智, 潘丽丽, 李健, 等. ETV6-RUNX1融合基因阳性儿童急性前体B淋巴细胞白血病的临床特征及预后分析[J]. 中华血液学杂志, 2021, 42(1):45-51.
|